The company exhibits severe financial distress with a Piotroski F-Score of 3/9, indicating weak financial health. Despite a high revenue growth rate of 65.90%, profitability is deeply negative, with an ROA of -45.76% and negative margins across all key metrics. The stock trades at a fraction of its $140.84 intrinsic value estimate, but this reflects extreme risk rather than undervaluation, as balance sheet weaknesses and lack of analyst coverage suggest high uncertainty. Technical indicators and insider sentiment are also bearish, reinforcing the deteriorating fundamentals.